GlassScriptPhysician profile
William Bonis
NPI 1689779209
$20,499.18
in general payments reported to CMS, 2019-2025
24 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $2,505 · 2021: $754 · 2022: $77.20 · 2023: $1,170 · 2024: $416 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,645 · Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,645.00 |
| Food and Beverage | $504.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $9,937.69 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $2,300.00 | 2019 | |
| Exelixis INC. | $2,050.00 | 2019 | |
| Glaxosmithkline, LLC. | $1,950.00 | 2020 | |
| Janssen Scientific Affairs, LLC | $1,170.00 | 2023 | Rybrevant |
| Astellas Pharma US INC | $599.99 | 2019-2021 | |
| Amgen INC. | $467.00 | 2019-2021 | |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2020 | |
| Cardinal Health 110 LLC | $275.00 | 2025 | |
| Zynex Medical, INC. | $258.78 | 2025 | Nexwave |
| Sobi, INC | $200.00 | 2024 | |
| Nalu Medical, INC. | $137.41 | 2024 | Nalu Neurostimulation System |
| Pfizer INC. | $110.77 | 2019-2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $98.74 | 2019 | |
| Allergan, INC. | $96.05 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.50 | 2019 | |
| Curonix LLC | $78.92 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $45.40 | 2022 | |
| Medtronic USA, INC. | $29.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.36 | 2025 | Libtayo |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bonis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.